Janney Montgomery Scott
KNSA icon

Janney Montgomery Scott’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Janney Montgomery Scott’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-28,231
Closed -$525K – 2767
2024
Q2 		$525K Buy
28,231
+1,388
+5% +$26K ﹤0.01% 1844
2024
Q1 		$530K Buy
26,843
+1,940
+8% +$37.9K ﹤0.01% 1953
2023
Q4 		$437K Buy
+24,903
New +$409K ﹤0.01% 2004

Other funds holding KNSA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Janney Montgomery Scott's KNSA Position: Q3 2024 in Review

Janney Montgomery Scott sold out of Kiniksa Pharmaceuticals (KNSA) in Q3 2024, closing a stake of 28,231 shares — an estimated $525K sold.

Janney Montgomery Scott first reported a position in KNSA in Q4 2023 and held it in 3 quarters. The position peaked at $530K in Q1 2024. 176 funds tracked by Wall St. Rank hold KNSA as of Q3 2024.

  • Janney Montgomery Scott reported no remaining Kiniksa Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Janney Montgomery Scott sold 28,231 Kiniksa Pharmaceuticals shares in Q3 2024, an estimated $525K.
  • Janney Montgomery Scott first reported a position in Kiniksa Pharmaceuticals in Q4 2023 and held it in 3 quarters.
  • Janney Montgomery Scott's Kiniksa Pharmaceuticals position peaked at $530K in Q1 2024.
  • 176 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2024.

Based on Janney Montgomery Scott's 13F filing for Q3 2024, filed 29 Oct 2024.